Director/PDMR Shareholding
5 February 2018 14:00 GMT TRANSACTION BY PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES Disclosure under Article 19 of the EU Market Abuse Regulation AstraZeneca PLC (the Company) announces that, on 2 February 2018, it was notified by Philip Broadley, a Non-Executive Director of the Company, that, on 2 February 2018, Mr Broadley purchased 415 Ordinary Shares of $0.25 each in the Company (Shares) at a price of 4846.3645 pence per Share. The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail. 1 Details of the